膀胱癌 (BC) 是一个重大的全球健康问题，每年有超过 500,000 例新发病例和 200,000 例死亡，这凸显了准确分期和有效管理的必要性。传统的诊断技术，如膀胱镜检查和经尿道切除术，是基础性的，但在准确评估浸润深度方面存在局限性。这些限制包括分期不足和程序变异的可能性，这可能会严重影响治疗决策。本综述重点关注多参数磁共振成像 (mpMRI) 在 BC 诊断和分期中的作用，特别强调膀胱成像报告和数据系统 (VI-RADS) 框架。通过提高解释一致性和诊断准确性，mpMRI 和 VI-RADS 提供肿瘤特征和浸润深度的详细可视化，同时减少对更具侵入性的传统方法的需求。这些进步不仅提高了分期准确性，而且还增强了治疗计划，强调了先进成像在不断发展的 BC 管理和积极影响患者治疗结果中的重要性。版权所有 © 2024 Wolters Kluwer Health, Inc. 保留所有权利。

Bladder cancer (BC) is a significant global health concern, with over 500,000 new cases and 200,000 deaths annually, emphasizing the need for accurate staging and effective management. Traditional diagnostic techniques, such as cystoscopy and transurethral resection, are fundamental but have limitations in accurately assessing the depth of invasion. These limitations include the possibility of understaging and procedural variability, which can significantly impact treatment decisions. This review focuses on the role of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis and staging of BC, particularly emphasizing the Vesical Imaging-Reporting and Data System (VI-RADS) framework. By enhancing interpretive consistency and diagnostic accuracy, mpMRI and VI-RADS offer detailed visualization of tumor characteristics and depth of invasion, while reducing the need for more invasive traditional methods. These advancements not only improve staging accuracy but also enhance treatment planning, underscoring the importance of advanced imaging in evolving BC management and positively influencing patient outcomes.Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.